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Introduction
Knee osteoarthritis (OA) represents a significant public health challenge internationally. The increasing burden of knee OA worldwide is evident from the results of the Global Burden of Disease Study 1 . This landmark study highlighted a major shift in the global burden of disease over the past 20 years from infectious diseases to non-communicable diseases including musculoskeletal conditions that are associated with significant disability 2 . This is supported by data from a range of developed countries that show steady growth in the rate of knee replacement surgeries performed predominantly for severe knee OA over the past two decades 3e5 .
Total knee replacements (TKRs) represent the majority of procedures performed, with only a small proportion of patients receiving unicompartmental knee replacement (UKR) 5, 6 . While joint replacement surgery is cost-effective 7 , planning for future healthcare demand is critical and requires robust population-level data on disease burden and healthcare utilisation.
Estimating the lifetime risk of joint replacement surgery is an evolving area within musculoskeletal epidemiology. This statistical approach is commonly used in the cardiovascular and cancer fields 8, 9 . The lifetime risk of TKR refers to the probability of having this surgical procedure over an individual's lifetime. Lifetime risk estimates provide a complementary approach to quantifying population-level disease burden and related use of healthcare services, and can be easily interpreted by health policymakers, clinicians and patients (as they are expressed as percentages). A key advantage of the lifetime risk statistic is that it provides a cumulative measure of risk that incorporates population life expectancy and all-cause mortality. Data on the lifetime risk of TKR surgery are limited. Research from the United Kingdom found that the lifetime risk of TKR had increased markedly over a 15-year period from 1991 to 2006, particularly for women 10 . In the United States, Weinstein et al.
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used national health survey data to estimate the cumulative lifetime risk of TKR, although changes in risk over time were not evaluated. Most recently, Bohensky and colleagues used hospital administrative data to estimate the lifetime risk of TKR in the state of Victoria, Australia 12 . A clear increase in the lifetime risk of TKR was evident over a nine-year period (1999e2008), most notably for females. Previous studies investigating the lifetime risk of TKR have all obtained data on joint replacement utilisation from observational studies or health system administrative datasets, which have known limitations around generalisability, completeness and accuracy. The use of population-based procedure data from national arthroplasty registries with almost complete coverage would enable more precise estimates of the lifetime risk of TKR. While a number of earlier studies have compared TKR incidence rates or utilisation rates between countries 4,6,13e15 , an international comparison of the lifetime risk of TKR has not been undertaken. The present study aimed to: estimate and compare the lifetime risk of primary TKR for OA in five countries; describe change in lifetime risk over a ten-year period (2003e2013); and examine changes in utilisation rates of primary TKR and UKR performed for OA over time.
Methods

Study design
A multi-national, population-level retrospective analysis was undertaken.
Data sources
We obtained data on all primary TKR and UKR procedures performed for OA from 1 January 2003 to 31 
Data analysis
Data were categorised into pre-specified age groups for analysis: <40 years, 40e49 years, 50e59 years, 60e69 years, 70e79 years and 80 years. A 'standardised lifetime risk' calculation incorporating age-specific rates 17 Similar to previous methods 15, 19 , overall and age-based utilisation rates for TKR were calculated for each country in 2003 and 2013 by summing the count of procedures from each registry and dividing by the relevant population (with regard to gender and age group) for that year. These are reported as TKR utilisation rates per 100,000 population, with separate calculations for males and females. Where bilateral TKRs were performed, these were counted as two procedures to avoid underestimating the true utilisation of TKR. For UKR, only overall utilisation rates were calculated due to the relatively small numbers of procedures performed. Table I summarises the population characteristics for each country. While population size varied substantially across the five countries, the gender distribution was similar. Life expectancy was comparable across the countries and all countries experienced an increase in life expectancy from 2003 to 2013. Demographic data relating to primary TKR use are also presented in Table I . In 2003 and 2013, the majority of TKR procedures in each country were undertaken for females. The proportion of TKRs performed for people aged 60 years increased over time for all countries, from 15.8% to 17.1% in Australia, from 17.2% to 17.7% in Denmark, from 12.7% to 17.4% in Finland, from 11.3% to 16.4% in Norway, and from 13.1% to 16.1% in Sweden. The proportion of TKRs performed for the oldest individuals (those aged 80 years) decreased over the 10-year period in all countries except Finland (Table I ). In 2003, the majority of TKR procedures in each country were performed for the 70e79 age group (Table I) . In 2013, this was still evident for Denmark, Finland and Sweden, although TKR was most frequently performed for the 60e69 age group in Australia and Norway at this time point. In 2013, the lowest lifetime risk for females was seen in Norway and the greatest lifetime risk for females was in Finland, closely followed by Australia (Table II) . For males, the lowest lifetime risk of TKR was in Norway and the highest lifetime risk was in Australia. Similar to the 2003 data, females consistently demonstrated a higher lifetime risk of TKR across all countries in 2013. The difference in lifetime risk between sexes was greatest in Finland, where the risk for females in 2013 was almost double the risk for males (22.79% vs 11.68%; P < 0.05).
Results
Population characteristics and demographics of TKR
Comparison of lifetime risk of TKR between countries
Changes in lifetime risk of TKR over time
Each country demonstrated a significant increase in the lifetime risk of TKR from 2003 to 2013 for both females and males. For females, the greatest absolute increases in lifetime risk over time were evident for Australia and Denmark (Fig. 1) , while Finland and Norway had the smallest absolute change. All five countries also 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 demonstrated significant increases in the lifetime risk of TKR for males over time (Fig. 2) . Australia had the greatest absolute increase, while the other countries showed smaller absolute increases.
Sensitivity analyses incorporating both TKR and UKR data produced similar results (Supplementary material), with marked between-country variation and significant increases over time in the combined lifetime risk of TKR and UKR observed for both sexes in all countries.
Age-specific utilisation rates for primary TKR For all countries, the greatest TKR utilisation rates were observed for people aged between 70 and 79 years and this was evident for both sexes and at both time points (Table III) . Across the countries, females aged 70e79 years in Finland experienced the highest rate of TKR (1770 procedures per 100,000 population in 2013). This rate was over 1.5 times higher than the utilisation rate for similarly-aged females in Australia and approximately three times higher than the rate for 70e79 year old females in Norway, Denmark, and Sweden. While utilisation rates for people aged 50 years were low, each country demonstrated an increase in TKR rates over time for females and males aged 40e49 years, 50e59 years, 60e69 years, 70e79 years and 80 years (Table III) .
Overall utilisation of UKR surgery
Compared to the number of TKR procedures performed, utilisation of UKR in each country was relatively low. In 2003, the number of UKR procedures ranged from 426 (in Norway) to 4070 (in Australia). In 2013, the number of procedures ranged from 276 (in Finland) to 2056 (in Australia). As a proportion of all knee replacement procedures, UKR utilisation decreased substantially in all countries from 2003 to 2013; from 16.2% to 4.6% in Australia, from 15.6% to 5.5% in Denmark, from 7.0% to 2.8% in Finland, from 16.0% to 9.7% in Norway, and from 12.5% to 3.7% in Sweden.
When population size was taken into account, a reduction in UKR utilisation rate over time was also evident for all countries. The greatest reductions were observed for Australia (from 20.6 UKR procedures per 100,000 population in 2003 to 8.9 procedures per 100,000 in 2013) and Sweden (from 10.6 to 4.9 UKR procedures per 100,000). Smaller reductions in utilisation rates were seen for Denmark (from 9.9 to 6.4 UKR procedures per 100,000), Finland (from 8.8 to 5.1 UKR procedures per 100,000) and Norway (from 9.4 to 8.5 UKR procedures per 100,000).
Discussion
This study is the first to use population-based arthroplasty registry data to estimate the lifetime risk of TKR at the national level, and to compare lifetime risk between countries and over time. We used data from five well-validated registries to obtain the most accurate information on TKR utilisation. We found a marked increase in the lifetime risk of primary TKR for OA in all countries over the ten-year study period, and substantial variation between countries in the utilisation of TKR. These lifetime risk estimates advance our understanding of population-level knee OA disease burden and healthcare utilisation, beyond data from the Global Burden of Disease Study that were modelled using systematic reviews of OA prevalence and incidence 1 , and beyond published TKR incidence or utilisation rates that do not consider life expectancy, age-specific mortality, or whether individuals have multiple surgical procedures 13, 15 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 The observed international variation in lifetime risk is unlikely to be explained purely by differences in knee OA prevalence, given the overlap in prevalence data for the five included countries 20e25 .
It is possible that differences in OA severity distributions may have contributed to our findings, although country-level severity data are not available to confirm this hypothesis. 28 .3% in 2011 but these estimates are based on measured height and weight data rather than self-reported data (the latter tend to under-report obesity). As high-income countries, life expectancy in Australia and the Nordic countries was similar and unlikely to have contributed to the international variation in lifetime risk.
Longer life expectancy for females is likely, however, to have contributed to the higher lifetime risk of TKR seen for females in all countries.
The most plausible explanation for the between-country differences in lifetime risk of TKR is international variation in health system factors. These include (but are not limited to) differences in local indications for surgery, access to surgery, healthcare funding and health workforce issues. Earlier research has shown significant international variation in the pre-operative status of people undergoing joint replacement for OA 27, 28 , suggesting differing clinical thresholds for performing surgery. The higher lifetime risk in Australia could also relate to increased access to surgery within the private healthcare system. In contrast, orthopaedic surgeons in the Nordic countries might be more likely to consider non-surgical management, given the availability of region-based OA prevention and management programs that actively encourage people to trial physiotherapy, disease education and exercise prior to considering surgery. These include the 'Better management of patients with OsteoArthritis' (BOA) program in Sweden . However, while conservative management programs might improve OA symptoms and delay the need for TKR surgery 32 , whether they can ultimately reduce an individual's lifetime risk is not known. Personal factors could also play a role in promoting the uptake of TKR in individual countries and increasing lifetime risk; for example, greater acceptance of joint replacement surgery in the community, cultural factors, more exposure to successful outcomes among peers, and access to paid leave or injury compensation schemes. The high lifetime risk in Finland might relate to local patient preferences for surgery, with registry research suggesting that Finnish baby-boomers elect to undergo TKR when their OA symptoms are relatively mild 33 . It is not clear why Norway had the lowest lifetime risk of TKR for both sexes in 2013 but this could relate to their relatively high utilisation of UKR and the comparatively good patient-reported outcomes for UKR in that country 34 , although a recent systematic review reported higher revision rates than for TKR 35 . * The overall utilisation rate was calculated using the total number of procedures for females (or males) as the numerator and the number of females (or males) in the population as the denominator. Age-specific utilisation rates were calculated using the number of procedures for each age group as the numerator and the age-specific population as the denominator. Bilateral procedures performed within the same year were counted as two TKRs for calculating utilisation rates to avoid underestimating the true utilisation of TKR. y Four TKR procedures from Finland were excluded from the 2013 analyses due to missing data on gender. 5   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 The significant increases in lifetime risk over time for each country are also unlikely to relate simply to growth in OA prevalence. In contrast, Global Burden of Disease data showed that worldwide, the age-standardised prevalence of knee OA did not change significantly from 1990 to 2010 1 while in Finland, national health surveys have shown that the prevalence of knee OA among women has actually decreased over a 20-year period 20 . Our data showed that Australia experienced the greatest absolute change in lifetime risk over time (for both sexes), and this probably reflects 'catch up' of previous unmet need following the introduction of government financial incentives in 1999e2000 to promote the uptake of private health insurance cover. Finland also experienced considerable unmet need for TKR prior to 2005, with patients experiencing long delays in accessing surgery. New Finnish legislation introduced in 2005 specified maximum waiting times for orthopaedic consultation and TKR, and hospitals received additional resources to meet these requirements. Although this cannot be quantified, these macro-level initiatives would undoubtedly have contributed to the rise in lifetime risk of TKR in both Australia and Finland. While detailed information on policy changes in each country was not available, it is possible that changes to government healthcare policies in the other countries over the study period may have contributed to the growth observed. Our calculated utilisation rates showed the greatest burden of TKR was borne by the 70e79 age group in 2003 and 2013. Younger patients (those aged 40e59 years) demonstrated only a small absolute increase in utilisation rates over the ten-year period, and perhaps this reflects awareness of the relatively high TKR revision rates for younger individuals 36, 37 . These utilisation rates cannot be directly compared to other studies examining TKR incidence or utilisation rates between countries, predominantly due to differences in data sources and methods. The study by Kurtz et al. 13 used a combination of inpatient hospital administrative data and arthroplasty registry data. Their reported incidence rates were not stratified by age or sex and were calculated at different time points (2007e2010) than those used for our study. The authors also acknowledged hospital coding limitations, where it was not possible to consistently determine primary TKR from revision TKR, or TKR from UKR. Most recently, Pabinger et al. 15 compared TKR utilisation rates in OECD countries but separate analyses for males and females were not reported. Our research design has uniquely generated burden of knee OA estimates using national data from five countries. Combined, the five countries had a population of almost 49 million people and performed over 74,000 primary TKRs in 2013. A major strength of this study is our use of robust arthroplasty registry data to ensure accurate estimations of lifetime risk and enable fair international comparisons. The Nordic countries have led the world with regard to implementing and maintaining high-quality national arthroplasty registries and the five included registries have near-complete TKR capture at the population level. We counted all TKR procedures when calculating utilisation rates but were careful to avoid erroneously inflating our lifetime risk estimates by only counting bilateral TKR procedures at the patient-level for these analyses. Given that provision of TKR is highly age-related, the standardised lifetime risk approach was important for dealing with changes to a country's age structure over time (for example, growth in older age groups due to population ageing). In this way, standardised lifetime risk calculations are likely to more accurate for monitoring changes in lifetime risk and undertaking between-country comparisons than non-standardised methods. We also acknowledge the limitations of this research. We included all patients who received a primary TKR for OA in 2003 or 2013 (regardless of whether they had previously received a contralateral primary TKR), as from a clinical perspective these patients are still 'at risk' of having surgery in the years of interest. This method also accounts for the different establishment years for each registry, and reflects the challenges of estimating lifetime risk for conditions that can have multiple occurrences over time 38 or conditions that can affect more than one joint, in the case of knee OA. Annual lifetime risk was not calculated as annual life tables were not consistently available for all countries, and it is possible that fluctuations may have occurred over the tenyear study period. Finally, we acknowledge that there may be some variation in the coding of diagnoses and classification of knee replacement procedures between the national registries that cannot be accounted for in our analyses.
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